Literature DB >> 15279705

Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART).

Carlo Torti1, Giuliana Cologni, Maria Cristina Uccelli, Eugenia Quiros-Roldan, Luisa Imberti, Paolo Airó, Silvia Pirovano, Andrea Patroni, Valeria Tirelli, Giampiero Carosi.   

Abstract

Correlates of immune reconstitution after highly active antiretroviral therapy (HAART) are not completely understood, in particular as far as viro-immunological discordant responses are concerned. HIV-positive patients on stable HAART for > or = 1 year were recruited. Viro-immunological responses were categorized according to positive or negative area under the curve (AUC) variations for HIV plasma viral load (pVL) and CD4+ T-cell counts measured at least every 4 months. The following parameters were evaluated: lymphocyte spontaneous apoptosis (LSA), intracellular Bcl-2 expression in both CD4-CD45RA+ and CD4-CD45R0+, IL-7 and IL-15 plasma concentrations, and lymphocyte TRECs levels. Sixty-one patients were enrolled. A significant inverse correlation was found between CD4+ T-cell count and pVL AUC (r = 0.45; p = 0.0003). Patients with pVL response had higher levels of Bcl-2 in CD4-CD45R0+ (mean 65,409 MESF vs. 54,018 MESF; p = 0.089) and higher IL-15 (mean 1.34 pg/mL vs. 1.05 pg/mL; p = 0.069, respectively). Higher LSA and lower TRECs levels were found in viro-immunological non-responder patients with respect to those who had viro-immunological response (mean 24.84% vs. 14.89%; p = 0.01, and mean 17,796 copies/10(6) cells vs. 29,251 copies/10(6) cells; p = 0.68, respectively). Virological suppression may allow Bcl-2 and IL-15 hyperexpression during incomplete immune-reconstitution phase, while more complete immune reconstitution appeared to be marked by both high TRECs and low LSA levels, possibly indicating both central and peripheral CD4+ T-cell repopulations at this stage. Copyright Mary Ann Liebert, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15279705     DOI: 10.1089/0882824041310630

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  7 in total

1.  Early postseroconversion CD4 cell counts independently predict CD4 cell count recovery in HIV-1-postive subjects receiving antiretroviral therapy.

Authors:  Hemant Kulkarni; Jason F Okulicz; Greg Grandits; Nancy F Crum-Cianflone; Michael L Landrum; Braden Hale; Glenn Wortmann; Edmund Tramont; Michael Polis; Matthew Dolan; Alan R Lifson; Brian K Agan; Sunil K Ahuja; Vincent C Marconi
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

2.  Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients.

Authors:  Eugenia Quiros-Roldan; Federico Serana; Marco Chiarini; Cinzia Zanotti; Alessandra Sottini; Daria Gotti; Carlo Torti; Luigi Caimi; Luisa Imberti
Journal:  J Transl Med       Date:  2012-05-16       Impact factor: 5.531

3.  Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS.

Authors:  Vincent C Marconi; Greg Grandits; Jason F Okulicz; Glenn Wortmann; Anuradha Ganesan; Nancy Crum-Cianflone; Michael Polis; Michael Landrum; Matthew J Dolan; Sunil K Ahuja; Brian Agan; Hemant Kulkarni
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

4.  A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.

Authors:  Anupa Kamat; Vikas Misra; Edana Cassol; Petronela Ancuta; Zhenyu Yan; Cheng Li; Susan Morgello; Dana Gabuzda
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

Review 5.  HIV RNA suppression and immune restoration: can we do better?

Authors:  Marilia Rita Pinzone; Michelino Di Rosa; Bruno Cacopardo; Giuseppe Nunnari
Journal:  Clin Dev Immunol       Date:  2012-03-25

6.  Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.

Authors:  Girmay Desalegn; Aster Tsegaye; Dawit Gebreegziabiher; Abraham Aseffa; Rawleigh Howe
Journal:  BMC Immunol       Date:  2019-10-11       Impact factor: 3.615

7.  Candida colonisation in asymptomatic HIV patients attending a tertiary hospital in Benin City, Nigeria.

Authors:  Newton O Esebelahie; Ifeoma B Enweani; Richard Omoregie
Journal:  Libyan J Med       Date:  2013-03-18       Impact factor: 1.743

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.